Y-mAbs Therapeutics (YMAB) Insider Trading & Ownership

$13.15

+0.20 (+1.54%)

(As of 09/30/2024 ET)

Current Insider Ownership Percentage: 21.50%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $1.41 M
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $3.63 M

Get YMAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Y-mAbs Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

YMAB Insider Buying and Selling by Quarter

Ad Behind the Markets

NOTICE: You have until Tuesday, November 19th

On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex. And while it might sound crazy...

Click here for the ticker >>>

Y-mAbs Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/16/2024	Thomas Gad	Insider	Sell	30,000	$12.97	$389,100.00
9/13/2024	Thomas Gad	Insider	Sell	65,000	$13.47	$875,550.00
8/26/2024	Joris Wilms	COO	Sell	5,000	$14.69	$73,450.00
6/10/2024	Gerard Ber	Director	Sell	722	$12.00	$8,664.00
6/10/2024	Thomas Gad	Insider	Sell	35,000	$12.03	$421,050.00
5/31/2024	Bo Kruse	CFO	Sell	31,371	$12.07	$378,647.97
[Urgent!] Web3 Could Send One Crypto Soaring (Ad) Venture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years. Click here to review my research and unique strategy to score potential profits from this under-the-
5/23/2024	Thomas Gad	Insider	Sell	7,351	$13.00	$95,563.00
5/21/2024	Thomas Gad	Insider	Sell	25,000	$12.00	$300,000.00
3/5/2024	Vignesh Rajah	SVP	Sell	1,711	$16.53	$28,282.83
12/15/2023	Thomas Gad	Insider	Sell	50,000	$6.61	$330,500.00
12/13/2023	Thomas Gad	Insider	Sell	50,000	$6.58	$329,000.00
12/11/2023	Biotech Aps Wg	Director	Buy	102,863	$7.01	$721,069.63
12/7/2023	Biotech Aps Wg	Director	Buy	6,183	$6.50	$40,189.50
11/29/2023	Biotech Aps Wg	Director	Buy	51,837	$5.97	$309,466.89
11/27/2023	Johan Wedell-Wedellsborg	Director	Buy	62,516	$5.49	$343,212.84
11/20/2023	Thomas Gad	Insider	Sell	75,000	$5.30	$397,500.00

(Data available from 1/1/2013 forward)

YMAB Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Y-mAbs Therapeutics includes Biotech Aps Wg, Bo Kruse, Gerard Ber, Johan Wedell-Wedellsborg, Joris Wilms, Thomas Gad, and Vignesh Rajah. Learn more on insiders at YMAB.
: 21.50% of Y-mAbs Therapeutics stock is owned by insiders. Learn more on YMAB's insider holdings.
: The following insiders have purchased YMAB shares in the last 24 months: Biotech Aps Wg ($1,070,726.02), Johan Wedell-Wedellsborg ($1,325,003.84), and Vignesh Rajah ($5,879.40).
: Insiders have purchased a total of 326,334 YMAB shares in the last 24 months for a total of $2,401,609.26 bought.
: The following insiders have sold YMAB shares in the last 24 months: Bo Kruse ($378,647.97), Gerard Ber ($8,664.00), Joris Wilms ($73,450.00), Thomas Gad ($3,138,263.00), and Vignesh Rajah ($28,282.83).
: Insiders have sold a total of 376,155 Y-mAbs Therapeutics shares in the last 24 months for a total of $3,627,307.80 sold.